What you should know:
1. Xtant is not in compliance with three different sections of the NYSE’s American Company Guide because Xtant posted negative stockholder equity of $43.77 million as of Dec. 31, 2018, and had net losses in five of its most recent fiscal years.
2. Xtant must deliver a plan of compliance to NYSE American by May 4. Xtant must be compliant again by Oct. 4, 2020.
3. Xtant will continue to trade on the NYSE but will have the “.BC” designation added to its symbol to denote its noncompliant status.
More articles on devices:
Mississippi Sports Medicine and Orthopaedic Center physicians now using Zimmer Biomet’s ROSA Knee System — 3 details
Atlantic Orthopaedics & Sports Medicine adds Dr. Michael Morwood — 3 insights
Mercy Medical Center adds Dr. Lew Schon — 4 insights
